During the past decade, Conestoga Eye conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Conestoga Eye" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 3 trials as a collaborator and "Boston Children's Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Conestoga Eye" are "Amblyopia" (4 trials), "Dry Eye Syndromes" (1 trials), "Intermittent Exotropia" (1 trials) and "Keratoconjunctivitis Sicca" (1 trials). Many other conditions were trialed in "Conestoga Eye" in a lesser frequency.

Most popular intervention types in "Conestoga Eye" are "Device" (3 trials), "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Luminopia One" (2 trials), "Glasses" (1 trials), "KPI-121 0.25% Ophthalmic Suspension" (1 trials), "Non-overminus treatment" (1 trials) and "Overminus treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Conestoga Eye" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Conestoga Eye". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Conestoga Eye, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Conestoga Eye, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".